ロード中...
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
Gastric cardia adenocarcinoma (GCA) is the most aggressive subtype of gastric cancer with a high metastatic rate. In this report, we collected tumor tissue samples from 214 GCA cases and examined expression of CYR61, a target gene product of the Hippo-YAP/TAZ pathway, in the GCA tumors by immunohist...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058739/ https://ncbi.nlm.nih.gov/pubmed/27105510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8845 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|